Limosone Cream contains Clobetasol propionate 0.05% w/w, a potent topical corticosteroid indicated for the management of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The formulation is designed for external use and provides rapid anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses within the skin. Limosone Cream is primarily utilized in the treatment of conditions such as psoriasis, eczema, dermatitis, and lichen planus, where inflammation and itching are prominent. Due to its high potency, it should be applied sparingly to affected areas, avoiding prolonged use or application on large surface areas to minimize the risk of systemic absorption and adverse effects. The cream base facilitates ease of application and absorption while maintaining skin hydration. Patients are advised to use Limosone Cream under medical supervision, adhering strictly to prescribed dosage and duration to prevent potential side effects such as skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression. It is contraindicated in viral, bacterial, or fungal skin infections unless appropriate antimicrobial therapy is concurrently administered. Pregnant or breastfeeding women should consult a healthcare professional prior to use. Limosone Cream should be stored at room temperature, away from direct sunlight and moisture.